Production and application of polyclonal antibodies against SARS-CoV-2 viral spike protein. Development to rapid, highly sensitive diagnosis kit for early Corona viral detection among the population
K. Kavithaa, M. Paulpandi, V. Balachandar, M. Ramesh, A. Narayanasamy Disease Proteomics Laboratory, Department of Zoology, School of Life Sciences, Bharathiar University, Coimbatore, TN, India. swamyarul@gmail.com
Pathogenic novel coronavirus SARS-CoV-2 is a recently rising infection that causes a high death rate in contaminated individuals. Many of the individuals who are infected are unaware of the infection because they may be asymptomatic carriers of the virus.To early analyze the viral disease, we proposed advancement of SARS-CoV-2 spike (S) proteins-explicit polyclonal antibodies-based kit described in this specific circumstance. The tests, if made accessible from variety of makers, can help smooth out early immunodetection of the crown viral infection. The survey Safe and Patient Friendly Healthcare suggests early diagnosis as the key to patients recovering from this deadly ailment.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
K. Kavithaa, M. Paulpandi, V. Balachandar, M. Ramesh, A. Narayanasamy
Production and application of polyclonal antibodies against SARS-CoV-2 viral spike protein. Development to rapid, highly sensitive diagnosis kit for early Corona viral detection among the population
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 19
Pages: 10219-10221
DOI: 10.26355/eurrev_202010_23244